tiprankstipranks
Opus Genetics (IRD)
NASDAQ:IRD
US Market
Want to see IRD full AI Analyst Report?

Opus Genetics (IRD) Income Statement

1,281 Followers

Opus Genetics Income Statement

Last quarter (Q4 2025), Opus Genetics's total revenue was $3.87M, a decrease of -10.16% from the same quarter last year. In Q4, Opus Genetics's net income was $-16.52M. See Opus Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 14.20M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Gross Profit
$ 14.14M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Operating Expenses
$ 52.80M$ 73.07M$ 29.61M$ 21.62M$ 23.29M
Depreciation and Amortization
$ 53.00K$ 10.00K$ 6.00K$ 4.00K$ 4.00K
EBITDA
$ -38.60M$ -57.52M$ -9.97M$ 18.22M$ -56.69M
Operating Income
$ -38.60M$ -62.07M$ -10.56M$ 18.23M$ -22.70M
Other Income/Expenses
$ -10.99M$ 4.54M$ 589.00K$ -23.00K$ -33.99M
Pretax Income
$ -49.59M$ -57.53M$ -9.97M$ 18.20M$ -56.69M
Net Income
$ -49.59M$ -57.53M$ -9.99M$ 17.89M$ -56.69M
Per Share Metrics
Basic EPS
$ -0.80$ -2.15$ -0.46$ 0.90$ -3.82
Diluted EPS
$ -0.80$ -2.15$ -0.46$ 0.87$ -3.82
Weighted Average Shares Outstanding
622.22M 26.72M 21.59M 19.93M 14.85M
Weighted Average Shares Outstanding (Diluted)
622.22M 26.72M 21.59M 20.60M 14.85M
Currency in USD

Opus Genetics Earnings and Revenue History